卓正医疗今起招股：何小鹏及多家腾讯系AI企业参与基石，将Costco模式移植到健康消费行业

Core Viewpoint - Zhuozheng Medical, a leading company in the domestic health consumption industry, is set to launch its IPO from January 29 to February 3, 2026, with a global offering of 4.75 million shares priced between HKD 57.7 and HKD 66.6 [1] Group 1: Financial Performance - Zhuozheng Medical has achieved continuous revenue and profit growth despite challenges in the medical service industry, with revenues projected at RMB 470 million, RMB 690 million, and RMB 960 million from 2022 to 2024, reflecting a compound annual growth rate (CAGR) of 42.2% [2] - The company's gross profit has also increased significantly, with figures of RMB 43.98 million, RMB 130 million, and RMB 230 million over the same period, resulting in a CAGR of 126.7% [2] - Zhuozheng Medical turned profitable in 2024, with adjusted net profits of RMB -123 million, RMB -43.57 million, and RMB 10.7 million over the last three years, and an adjusted net profit of RMB 10.45 million in the first eight months of 2025 [2] - The net cash flow from operating activities has shown steady growth, with amounts of RMB 6.86 million, RMB 12.4 million, and RMB 17.1 million in the last three years, reaching RMB 11.2 million in the first eight months of 2025 [2] Group 2: Business Model - Zhuozheng Medical's revenue model is distinct, with over 85% of its income coming from cash payments and approximately 12% from commercial insurance, while income from national medical insurance is minimal [4] - The company has low marketing costs, with marketing expenses accounting for only 2.7%, 1.2%, and 1.7% of revenue from 2022 to 2024, primarily for brand personnel salaries rather than sales [4] - High customer retention is achieved through excellent customer reputation, with membership renewal rates of approximately 42%, 56%, 64%, and 67% from 2022 to 2025, and patient return rates of 75.7%, 78.2%, 80.0%, and 82.7% over the same period [5] Group 3: Growth Strategy - Zhuozheng Medical employs a business model similar to Costco, focusing on high-frequency health services and a family membership plan that encourages multiple visits across various specialties [7][8] - The company targets high-frequency health needs rather than low-frequency severe illnesses, extending customer engagement through a comprehensive service offering [7] - In 2024, Zhuozheng Medical served approximately 240,000 customers with around 900,000 visits, averaging nearly four visits per customer, significantly higher than traditional single-specialty medical institutions [8] Group 4: Investment and Market Position - Zhuozheng Medical has attracted significant investment interest, with notable shareholders including Tencent, which holds nearly 20% of the company, and other prominent investment firms [11] - The company has garnered attention from cornerstone investors, including leading firms in third-party testing and the electric vehicle sector, indicating strong market confidence in its business model and growth potential [11] - The backing from various Tencent-affiliated companies aligns with Zhuozheng Medical's AI transformation strategy, enhancing collaborative opportunities for future growth [11]